Co-expression of TIM-3 and CEACAMI promotes T cell exhaustion in colorectal cancer patients
Co-expression of TIM-3 and CEACAMI promotes T cell exhaustion in colorectal cancer patients
复制标题
TIM-3和CEACAMI的共表达促进结直肠癌患者T细胞耗竭
DOI：
10.1016/j.intimp.2016.12.024
复制
发表时间：
2017-02-01
影响因子：
5.6
通讯作者：
Hu, Lihua
中科院分区：
文献类型：
--
作者：
Zhang, Yang;Cai, Pengcheng;Hu, Lihua
T-cell immunoglobulin domain and mucin domain-3(TIM-3) is an activation induced inhibitory molecule involved in immune tolerance and is recently reported to induce T cell exhaustion which is mediated by carcinoembryonic antigen cell adhesion molecule 1 (CEACAMI), another well-known molecule expressed on activated T cells and involved in T cell inhibition. To investigate the expression of TIM-3 and CEACAMI on circulating CD8(+) T cells and tumor infiltrating lymphocytes (TILs), 65 diagnosed colorectal cancer (CRC) patients and 38 healthy controls were enrolled in this study and the results showed that TIM-3 and CEACAMI were both highly expressed on circulating CD8(+) T cells in CRC patients and elevated on TILs compared with paraneoplastic T cells, Furthermore, TIM-3(+) CEACAM1(+) CD8(+) T cells represented the most dysfunctional population with the least IFN-gamma, production. In addition, the expressions of TIM-3 and CEACAMI were correlated with advanced stage and could be independent risk factors for CRC. We for the first time to our knowledge suggested that co-expression of TIM-3 and CEACAM1 can mediate T cell exhaustion and may be potential biomarkers for CRC prediction, highlighting the possibility of being immunotherapy targets. (C) 2016 Elsevier B.V. All rights reserved.
